Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Steroid for COVID-19 Anosmia
NCT04569825Phase 1Unknown
- Sponsor
- University of Anbar
- Start
- Aug 2020
- Primary completion
- Sep 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of betamethasone in anosmia (4 arms), sponsored by University of Anbar. Primary endpoints: Recovery rate of anosmia at 30 days and Time to recovery of anosmia at 30 days. Status: unknown.
02
Drugs
betamethasone
03
Conditions
anosmia
Beyond the preview
Go deeper on NCT04569825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04569825.